The efficacy of anti-IL-4 receptor alpha monoclonal antibody (dupilumab), anti-IL-13 monoclonal antibody (tralokinumab), and anti-IL-6 monoclonal antibody (siltuximab) in alopecia areata is still under investigation [8]. The gene discussed is IL13; the disease is alopecia areata.